Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Chen Gefen"'
Autor:
G. Rechavi, Drorit Merkel, Avichai Shimoni, Chen Gefen, Jonathan Canaani, Yulia Volchek, Noga Shem-Tov, Arnon Nagler, Meital Nagar, Ronit Yerushalmi, Abraham Avigdor, Gabriel Heering, Ninette Amariglio
Publikováno v:
Oncotarget
A substantial segment of patients with acute myeloid leukemia (AML) will relapse following an initial response to induction therapy or will prove to be primary refractory. High-dose cytarabine and mitoxantrone (HiDAC/MITO) is an established salvage t
Autor:
Denkberg Galit, Oryan Makler, Gideon Rechavi, Ninette Amariglio, Kfir Oved, Yoram Reiter, Hila Novak, Omer Ziv, Chen Gefen-Dor, Sinik Keren, Roy Noy, Dina Segal, Jasmine Jacob-Hirsch
Publikováno v:
The Journal of Immunology. 178:2307-2317
CTLs act as the effector arm of the cell-mediated immune system to kill undesirable cells. Two processes regulate these effector cells to prevent self reactivity: a thymic selection process that eliminates autoreactive clones and a multistage activat
Autor:
Chen Gefen-Dor, Yoel Kloog, Marcelo Ehrlich, J. Jacob-Hirsch, B. Shai, V. Makovski, Gideon Rechavi
Publikováno v:
Cell Death & Disease
Mutations in tuberous sclerosis (TSC) genes cause the genetic disorder TSC, as well as other neoplasms, including lymphangioleiomyomatosis (LAM) and angiomyolipomas (AMLs). AMLs are benign renal tumors occur both in sporadic LAM and in TSC. As they c